ImmunologybioRxivPreprint
Targeting DNMT1 augments anti-tumor CD8⁺ T cell function
Maya G. Deshmukh, Danielle K. Sohai, Kamal Obbad…·Goran Micevic
This study shows that inhibiting DNMT1 improves CD8+ T cell function in the tumor microenvironment and enhances the effectiveness of immune checkpoint inhibitors in a melanoma model.
DOI 10.64898/2026.07.03.736412